HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

FK3000

from Stephania cepharantha (root tubers); structure in first source

Also Known As:

FK-3000

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - FK3000: 2

Experts

1.	Cho, Soon-Chang: 2 articles (01/2015 - 11/2012)
2.	Park, Dae-Hun: 2 articles (01/2015 - 11/2012)
3.	Bae, Chun-Sik: 1 article (01/2015)
4.	Bang, Mi-Ae: 1 article (01/2015)
5.	Choi, Yeonshik: 1 article (01/2015)
6.	Li, Yong-Chun: 1 article (01/2015)
7.	Lim, Seung-Kil: 1 article (01/2015)
8.	Shim, Jaegal: 1 article (01/2015)
9.	Xu, Hong De: 1 article (01/2015)
10.	Ahn, Sung-Hoon: 1 article (11/2012)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2015 - "The tumor size was smallest in the co-treatment group, indicating that FK-3000 may have a synergistic effect with Taxol. "
2.	Carcinoma (Carcinomatosis) 11/01/2012 - "FK-3000 can inhibit proliferation of carcinomas and arrest the growth of carcinoma cells through cytotoxic (apoptosis induction) and cytostatic (cell cycle arrest) effects. "
3.	Breast Neoplasms (Breast Cancer) 01/01/2015 - "The FK-3000 half maximal inhibitory concentration (IC50) in MDA-MB-231 breast carcinoma cells at 48 h was 0.52 µg/ml and it induced apoptosis in a dose- and time-dependent manner. "

Related Drugs and Biologics

1.	Cytostatic Agents
2.	Paclitaxel (Taxol)